J Virol. 1992 February; 66(2): 757-765
Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity.
J J de Jong,
J Goudsmit,
W Keulen,
B Klaver,
W Krone,
M Tersmette and
A de Ronde
Human Retrovirus Laboratory, The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
ABSTRACT
Chimeric human immunodeficiency virus type 1 (HIV-1) molecular clones differing only in the envelope V3 region were constructed. The V3 regions were derived from two HIV-1 isolates with a non-syncytium-inducing, non-T-cell-tropic phenotype and from four HIV-1 isolates with a syncytium-inducing, T-cell-tropic phenotype. When assayed in SupT1 cells, the two chimeric viruses with a V3 region derived from the non-syncytium-inducing isolates did not induce syncytia and showed a low level of replication. The four chimeric viruses with a V3 region derived from the syncytium-inducing isolates did induce syncytia and replicated efficiently in SupT1 cells. In A3.01 cells, which do not support syncytium formation, the V3 loop affected replication similarly. Upon prolonged culture in SupT1 cells, the phenotype of a non-syncytium-inducing, low-replicating chimeric HIV-1 converted into a syncytium-inducing, high-replicating phenotype. Mutations within the usually conserved GPGR tip of the loop, which were shown to be responsible for the conversion into the syncytium-inducing, high-replicating phenotype, had occurred. In vitro mutagenesis showed that coupled changes of amino acids at both sides of the tip of the V3 loop were able to convert the viral phenotype from non-syncytium-inducing, low replicating into syncytium inducing, high replicating. Our data show that the V3 loop is involved in both syncytium forming and replicative capacity of HIV-1.
J Virol. 1992 February; 66(2): 757-765
This article has been cited by other articles:
-
Lin, G., Bertolotti-Ciarlet, A., Haggarty, B., Romano, J., Nolan, K. M., Leslie, G. J., Jordan, A. P.-O., Huang, C.-c., Kwong, P. D., Doms, R. W., Hoxie, J. A.
(2007). Replication-Competent Variants of Human Immunodeficiency Virus Type 2 Lacking the V3 Loop Exhibit Resistance to Chemokine Receptor Antagonists. J. Virol.
81: 9956-9966
[Abstract]
[Full Text]
-
Billington, J., Hickling, T. P., Munro, G. H., Halai, C., Chung, R., Dodson, G. G., Daniels, R. S.
(2007). Stability of a Receptor-Binding Active Human Immunodeficiency Virus Type 1 Recombinant gp140 Trimer Conferred by Intermonomer Disulfide Bonding of the V3 Loop: Differential Effects of Protein Disulfide Isomerase on CD4 and Coreceptor Binding. J. Virol.
81: 4604-4614
[Abstract]
[Full Text]
-
Delobel, P., Nugeyre, M.-T., Cazabat, M., Pasquier, C., Marchou, B., Massip, P., Barre-Sinoussi, F., Israel, N., Izopet, J.
(2007). Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies. J. Clin. Microbiol.
45: 1572-1580
[Abstract]
[Full Text]
-
Watabe, T., Kishino, H., Okuhara, Y., Kitazoe, Y.
(2006). Fold Recognition of the Human Immunodeficiency Virus Type 1 V3 Loop and Flexibility of Its Crown Structure During the Course of Adaptation to a Host. Genetics
172: 1385-1396
[Abstract]
[Full Text]
-
Pollakis, G., Abebe, A., Kliphuis, A., Chalaby, M. I. M., Bakker, M., Mengistu, Y., Brouwer, M., Goudsmit, J., Schuitemaker, H., Paxton, W. A.
(2004). Phenotypic and Genotypic Comparisons of CCR5- and CXCR4-Tropic Human Immunodeficiency Virus Type 1 Biological Clones Isolated from Subtype C-Infected Individuals. J. Virol.
78: 2841-2852
[Abstract]
[Full Text]
-
Nabatov, A. A., Pollakis, G., Linnemann, T., Kliphius, A., Chalaby, M. I. M., Paxton, W. A.
(2004). Intrapatient Alterations in the Human Immunodeficiency Virus Type 1 gp120 V1V2 and V3 Regions Differentially Modulate Coreceptor Usage, Virus Inhibition by CC/CXC Chemokines, Soluble CD4, and the b12 and 2G12 Monoclonal Antibodies. J. Virol.
78: 524-530
[Abstract]
[Full Text]
-
Jensen, M. A., Li, F.-S., van 't Wout, A. B., Nickle, D. C., Shriner, D., He, H.-X., McLaughlin, S., Shankarappa, R., Margolick, J. B., Mullins, J. I.
(2003). Improved Coreceptor Usage Prediction and Genotypic Monitoring of R5-to-X4 Transition by Motif Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences. J. Virol.
77: 13376-13388
[Abstract]
[Full Text]
-
Rangel, H. R., Weber, J., Chakraborty, B., Gutierrez, A., Marotta, M. L., Mirza, M., Kiser, P., Martinez, M. A., Este, J. A., Quinones-Mateu, M. E.
(2003). Role of the Human Immunodeficiency Virus Type 1 Envelope Gene in Viral Fitness. J. Virol.
77: 9069-9073
[Abstract]
[Full Text]
-
Cilliers, T., Nhlapo, J., Coetzer, M., Orlovic, D., Ketas, T., Olson, W. C., Moore, J. P., Trkola, A., Morris, L.
(2003). The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C. J. Virol.
77: 4449-4456
[Abstract]
[Full Text]
-
Liu, S.-L., Mittler, J. E., Nickle, D. C., Mulvania, T. M., Shriner, D., Rodrigo, A. G., Kosloff, B., He, X., Corey, L., Mullins, J. I.
(2002). Selection for Human Immunodeficiency Virus Type 1 Recombinants in a Patient with Rapid Progression to AIDS. J. Virol.
76: 10674-10684
[Abstract]
[Full Text]
-
Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J., Walker, J. M., Swanstrom, R.
(2002). Variability in the Human Immunodeficiency Virus Type 1 gp120 Env Protein Linked to Phenotype-Associated Changes in the V3 Loop. J. Virol.
76: 3852-3864
[Abstract]
[Full Text]
-
Shankarappa, R., Chatterjee, R., Learn, G. H., Neogi, D., Ding, M., Roy, P., Ghosh, A., Kingsley, L., Harrison, L., Mullins, J. I., Gupta, P.
(2001). Human Immunodeficiency Virus Type 1 Env Sequences from Calcutta in Eastern India: Identification of Features That Distinguish Subtype C Sequences in India from Other Subtype C Sequences. J. Virol.
75: 10479-10487
[Abstract]
[Full Text]
-
Ogert, R. A., Lee, M. K., Ross, W., Buckler-White, A., Martin, M. A., Cho, M. W.
(2001). N-Linked Glycosylation Sites Adjacent to and within the V1/V2 and the V3 Loops of Dualtropic Human Immunodeficiency Virus Type 1 Isolate DH12 gp120 Affect Coreceptor Usage and Cellular Tropism. J. Virol.
75: 5998-6006
[Abstract]
[Full Text]
-
York, J., Follis, K. E., Trahey, M., Nyambi, P. N., Zolla-Pazner, S., Nunberg, J. H.
(2001). Antibody Binding and Neutralization of Primary and T-Cell Line-Adapted Isolates of Human Immunodeficiency Virus Type 1. J. Virol.
75: 2741-2752
[Abstract]
[Full Text]
-
Gunthard, H. F., Frost, S. D. W., Leigh-Brown, A. J., Ignacio, C. C., Kee, K., Perelson, A. S., Spina, C. A., Havlir, D. V., Hezareh, M., Looney, D. J., Richman, D. D., Wong, J. K.
(1999). Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy. J. Virol.
73: 9404-9412
[Abstract]
[Full Text]
-
Kato, K., Sato, H., Takebe, Y.
(1999). Role of Naturally Occurring Basic Amino Acid Substitutions in the Human Immunodeficiency Virus Type 1 Subtype E Envelope V3 Loop on Viral Coreceptor Usage and Cell Tropism. J. Virol.
73: 5520-5526
[Abstract]
[Full Text]
-
Esté, J. A., Cabrera, C., Blanco, J., Gutierrez, A., Bridger, G., Henson, G., Clotet, B., Schols, D., De Clercq, E.
(1999). Shift of Clinical Human Immunodeficiency Virus Type 1 Isolates from X4 to R5 and Prevention of Emergence of the Syncytium-Inducing Phenotype by Blockade of CXCR4. J. Virol.
73: 5577-5585
[Abstract]
[Full Text]
-
Kimata, J. T., Gosink, J. J., KewalRamani, V. N., Rudensey, L. M., Littman, D. R., Overbaugh, J.
(1999). Coreceptor Specificity of Temporal Variants of Simian Immunodeficiency Virus Mne. J. Virol.
73: 1655-1660
[Abstract]
[Full Text]
-
Esté, J. A., Cabrera, C., De Clercq, E., Struyf, S., Van Damme, J., Bridger, G., Skerlj, R. T., Abrams, M. J., Henson, G., Gutierrez, A., Clotet, B., Schols, D.
(1999). Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor. Mol. Pharmacol.
55: 67-73
[Abstract]
[Full Text]
-
Nijhuis, M., Boucher, C. A. B., Schipper, P., Leitner, T., Schuurman, R., Albert, J.
(1998). Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc. Natl. Acad. Sci. USA
95: 14441-14446
[Abstract]
[Full Text]
-
Grovit-Ferbas, K., Ferbas, J., Gudeman, V., Sadeghi, S., Goetz, M. B., Giorgi, J. V., Chen, I. S. Y., O'Brien, W. A.
(1998). Potential Contributions of Viral Envelope and Host Genetic Factors in a Human Immunodeficiency Virus Type 1-Infected Long-Term Survivor. J. Virol.
72: 8650-8658
[Abstract]
[Full Text]
-
Edinger, A. L., Hoffman, T. L., Sharron, M., Lee, B., Yi, Y., Choe, W., Kolson, D. L., Mitrovic, B., Zhou, Y., Faulds, D., Collman, R. G., Hesselgesser, J., Horuk, R., Doms, R. W.
(1998). An Orphan Seven-Transmembrane Domain Receptor Expressed Widely in the Brain Functions as a Coreceptor for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus. J. Virol.
72: 7934-7940
[Abstract]
[Full Text]
-
Hoffman, T. L., Stephens, E. B., Narayan, O., Doms, R. W.
(1998). HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors. Proc. Natl. Acad. Sci. USA
95: 11360-11365
[Abstract]
[Full Text]
-
Follis, K. E., Trahey, M., LaCasse, R. A., Nunberg, J. H.
(1998). Continued Utilization of CCR5 Coreceptor by a Newly Derived T-Cell Line-Adapted Isolate of Human Immunodeficiency Virus Type 1. J. Virol.
72: 7603-7608
[Abstract]
[Full Text]
-
Wang, J., Roderiquez, G., Oravecz, T., Norcross, M. A.
(1998). Cytokine Regulation of Human Immunodeficiency Virus Type 1 Entry and Replication in Human Monocytes/Macrophages through Modulation of CCR5 Expression. J. Virol.
72: 7642-7647
[Abstract]
[Full Text]
-
Owen, S. M., Ellenberger, D., Rayfield, M., Wiktor, S., Michel, P., Grieco, M. H., Gao, F., Hahn, B. H., Lal, R. B.
(1998). Genetically Divergent Strains of Human Immunodeficiency Virus Type 2 Use Multiple Coreceptors for Viral Entry. J. Virol.
72: 5425-5432
[Abstract]
[Full Text]
-
Speck, R. F., Penn, M. L., Wimmer, J., Esser, U., Hague, B. F., Kindt, T. J., Atchison, R. E., Goldsmith, M. A.
(1998). Rabbit Cells Expressing Human CD4 and Human CCR5 Are Highly Permissive for Human Immunodeficiency Virus Type 1 Infection. J. Virol.
72: 5728-5734
[Abstract]
[Full Text]
-
Cho, M. W., Lee, M. K., Carney, M. C., Berson, J. F., Doms, R. W., Martin, M. A.
(1998). Identification of Determinants on a Dualtropic Human Immunodeficiency Virus Type 1 Envelope Glycoprotein That Confer Usage of CXCR4. J. Virol.
72: 2509-2515
[Abstract]
[Full Text]
-
Lee, B., Doranz, B. J., Ratajczak, M. Z., Doms, R. W.
(1998). An Intricate Web: Chemokine Receptors, HIV-1 and Hematopoiesis. Stem Cells
16: 79-88
[Abstract]
[Full Text]
-
van der Hoek, L, Sol, C., Maas, J, Lukashov, V., Kuiken, C., Goudsmit, J
(1998). Genetic differences between human immunodeficiency virus type 1 subpopulations in faeces and serum. J. Gen. Virol.
79: 259-267
[Abstract]
-
Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S.-H., Goetz, M. B., Daar, E. S., Doms, R. W., O'Brien, W. A.
(1997). A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor. J. Exp. Med.
186: 1395-1400
[Abstract]
[Full Text]
-
Esté, J. A., Schols, D., De Vreese, K., Van Laethem, K., Vandamme, A.-M., Desmyter, J., De Clercq, E.
(1997). Development of Resistance of Human Immunodeficiency Virus Type 1 to Dextran Sulfate Associated with the Emergence of Specific Mutations in the Envelope gp120 Glycoprotein. Mol. Pharmacol.
52: 98-104
[Abstract]
[Full Text]
-
Yamaguchi, Y., Gojobori, T.
(1997). Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc. Natl. Acad. Sci. USA
94: 1264-1269
[Abstract]
[Full Text]
-
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., Landau, N. R.
(1997). Change in Coreceptor Use Correlates with Disease Progression in HIV-1-Infected Individuals. J. Exp. Med.
185: 621-628
[Abstract]
[Full Text]
-
Groenink, M, Fouchier, R., Broersen, S, Baker, C., Koot, M, van't Wout, A., Huisman, H., Miedema, F, Tersmette, M, Schuitemaker, H
(1993). Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science
260: 1513-1516
[Abstract]
-
Hwang, S., Boyle, T., Lyerly, H., Cullen, B.
(1992). Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science
257: 535-537
[Abstract]
-
Pollakis, G., Kang, S., Kliphuis, A., Chalaby, M. I. M., Goudsmit, J., Paxton, W. A.
(2001). N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization. J. Biol. Chem.
276: 13433-13441
[Abstract]
[Full Text]
Copyright © 1992 by the American Society for Microbiology. All rights reserved.